Japan, Nov. 12 -- SAWAI PHARMACEUTICAL CO LTD has got intellectual property rights for 'APIXABAN-CONTAINING ORALLY DISINTEGRATING TABLET AND MANUFACTURING METHOD THEREOF.' Other related details are as follows:

Application Number: JP,2022-156497

Category (FI): A61K31/4545,A61K47/38,A61K47/32,A61P7/02,A61K9/20

Stage: Grant (IP right granted following substantive examination.)

Filing Date: Sept. 29, 2022

Publication Date: April 10, 2023

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication....